CVS Health (CVS) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1266501006

Health Insurance, Pharmacy Services, Prescription Drugs, Over-the-Counter Products

CVS Health Corporation is a leading healthcare company in the United States, dedicated to providing a range of health solutions to individuals, employers, and healthcare providers. The company operates through three main segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness.

The Health Care Benefits segment offers a variety of health insurance products and services, including traditional, voluntary, and consumer-directed plans. This segment caters to a diverse range of clients, including employer groups, individuals, college students, part-time and hourly workers, health plans, healthcare providers, governmental units, government-sponsored plans, labor groups, and expatriates. These insurance products and services are designed to provide affordable and accessible healthcare to people from all walks of life.

The Health Services segment is focused on providing pharmacy benefit management solutions to employers, insurance companies, unions, government employee groups, health plans, and other sponsors of health benefit plans. This segment offers a range of services, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. These services are designed to help clients manage their healthcare costs and improve health outcomes.

The Pharmacy & Consumer Wellness segment is responsible for selling prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment operates online retail pharmacy websites, LTC pharmacies, on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies, and branches for infusion and enteral nutrition services. Additionally, this segment provides pharmacy consulting and other ancillary services to care facilities and other care settings.

CVS Health Corporation was previously known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. The company was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island. With a strong commitment to improving healthcare outcomes and reducing healthcare costs, CVS Health Corporation is a leader in the healthcare industry.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for CVS Health (CVS) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for CVS Health (CVS) - Stock Price & Dividends

CVS Stock Overview

Market Cap in USD 76,502m
Sector Healthcare
Industry Healthcare Plans
GiC SubIndustry Health Care Services
TER 0.00%
IPO / Inception 1984-12-17

CVS Stock Ratings

Growth 5y 21.9
Fundamental 18.0
Dividend 7.40
Rel. Performance vs Sector -2.00
Analysts 3.89/5
Fair Price Momentum 67.66 USD
Fair Price DCF 177.70 USD

CVS Dividends

Yield 12m 4.14%
Yield on Cost 5y 5.53%
Dividends CAGR 5y 3.89%
Payout Consistency 96.8%

CVS Growth Ratios

Growth 12m -8.65%
Growth Correlation 12m 1%
Growth Correlation 3m -44%
CAGR 5y 5.95%
CAGR/Mean DD 5y 0.40
Sharpe Ratio 12m -0.46
Alpha vs SP500 12m -30.96
Beta vs SP500 5y weekly 0.77
ValueRay RSI 63.11
Volatility GJR Garch 1y 25.01%
Price / SMA 50 0.89%
Price / SMA 200 -11.4%
Current Volume 20871.3k
Average Volume 20d 13098.2k

External Links for CVS Stock

Wall Street JournalBenzingaYahoo Finance
Fund Manager Positions
What is the price of CVS stocks?
As of June 22, 2024, the stock is trading at USD 61.37 with a total of 20,871,253 shares traded.
Over the past week, the price has changed by +1.91%, over one month by +7.07%, over three months by -20.83% and over the past year by -7.55%.
What are the forecast for CVS stock price target?
According to ValueRays Forecast Model, CVS CVS Health will be worth about 73.1 in June 2025. The stock is currently trading at 61.37. This means that the stock has a potential upside of +19.06%.
Issuer Forecast Upside
Wallstreet Target Price 67 9.21
Analysts Target Price 90.2 46.9
ValueRay Target Price 73.1 19.1

Understanding CVS Health Corp: A Comprehensive Overview

History of CVS Health Corp

CVS Health Corp, originally named Consumer Value Stores, embarked on its journey in 1963, starting as a health and beauty products retailer in Lowell, Massachusetts. Over decades, it has evolved, marking milestones that shaped it into a frontline pharmacy innovation company. Key transformations include the introduction of pharmacy benefit management (PBM) services in 2007, further expansion into healthcare services, and the pivotal acquisition of Aetna in 2018. This expansion has cemented CVS's role in the healthcare ecosystem, moving beyond retail to become a holistic healthcare provider.

Core and Side Businesses

The core business of CVS Health encompasses its retail pharmacy services, which operate under the CVS Pharmacy brand, providing prescription medications, health products, and wellness goods. Additionally, it runs walk-in medical clinics known as MinuteClinic that offer treatments and vaccinations. A significant part of CVS's operations also lies in its healthcare benefits segment, managed under Aetna, catering to millions with health insurance products and services.

Beyond these, CVS Health is engaged in pharmacy benefit management (PBM) through CVS Caremark, optimizing prescription drug benefits on behalf of health insurers, employers, and government agencies. Its comprehensive approach also extends to specialty pharmacy services, focusing on chronic and genetic diseases' treatments. While these are the core segments, CVS continuously innovates in digital health and other side ventures aiming at enhancing overall healthcare accessibility and affordability.

Current Market Status

As of 2023, CVS Health Corp maintains a robust presence in the health care market, benefiting from a wide network of physical locations and an expanding array of health services. The company has adeptly navigated the challenges and opportunities presented by the global pandemic, accelerating its digital transformation and telehealth services. Its strategic acquisitions, like that of Aetna, continue to diversify its revenue streams and strengthen its market position against competitors. The financial performance demonstrates significant resilience and potential for growth, reflecting its adaptability and commitment to healthcare innovation.